Cardiac amyloidosis in Latin America: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group.

ABSTRACT:

Background

Cardiac amyloidosis (CA) is an under-diagnosed disease presenting as a restrictive cardiomyopathy with high morbidity and mortality. Wild-type transthyretin amyloid cardiomyopathy (ATTR-CM) is mostly seen in elderly patients, with increasing prevalence as life expectancy is growing. New diagnostic imaging techniques and treatments allow for a better prognosis, but lack of clinical awareness delays timely diagnosis and appropriate management. Our purpose was to investigate the knowledge of clinicians regarding ATTR-CM and to assess the availability of imaging resources in the Latin-American region.

Methods and results

Two online surveys were distributed among clinicians and nuclear medicine professionals, respectively: one asking about awareness of CA in different

SUBMITTER: Mut F 

PROVIDER: S-EPMC9154028 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature